Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

The main goals of chronic obstructive pulmonary disease (COPD) management include treatment of symptoms and prevention of exacerbations. Current guidelines recommend use of one or more long-acting ...

Long-term oxygen therapy not beneficial for COPD with moderate desaturation. What is the risk of future COPD exacerbations, hospitalizations, and death among patients with COPD who had 1 or 0 ...

In patients with chronic obstructive pulmonary disease (COPD), increasing frequency and severity of exacerbations were linked to a higher risk of future exacerbations and all-cause and COPD-related ...

Most chronic obstructive pulmonary disease (COPD) exacerbations were observed in those not treated with controller medications, but less than half of patients in the study received controller ...

Patients hospitalized for acute COPD exacerbation had reduced odds for in-hospital mortality if they had a prior history of bariatric surgery, according to data presented at the CHEST Annual Meeting.“ ...

—A new study finds that some patients are proactive (they seek immediate treatment), while others tough it out (wishing to avoid the ‘hassle’ or ‘inconvenience’). What can clinicians do to better ...

The risk of a CV adverse event of special interest did decrease over time after a moderate or severe COPD exacerbation. This article is part of MPR’s coverage of the CHEST Virtual 2020 meeting. In the ...

New research shows that individual exacerbations in chronic obstructive lung disease (COPD) themselves increase the likelihood of repeat exacerbations, even after five days of full, asymptomatic ...

bronchodilators, COPD Triple therapy with budesonide/glycopyrrolate/formoterol fumarate in patients with COPD, regardless of exacerbation history, reduced ...

telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...

Paris and Tarrytown, N.Y. November 27, 2023. The second Dupixent® (dupilumab) investigational Phase 3 chronic obstructive pulmonary disease (COPD) trial (NOTUS) has shown that Dupixent significantly ...